country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Art. -Nr.: HY-175202

Copy Link Print Information

CIDD-8633

Name: CIDD-8633
Brand: MedChemExpress
SKU: HY-175202
Price: 105.00 USD
Availability: InStock
Rating: 5 (1 reviews)

Kundenbewertung

Based on 1 Customer Validation

CIDD-8633 is a potent DDR2 inhibitor with an IC₅₀ of 6.105 μM. CIDD-8633 inhibits cell migration and halts the cell cycle and induces apoptosis, significantly suppressing pancreatic ductal adenocarcinoma (PDAC) tumor growth. CIDD-8633 can be used for the study of pancreatic cancer such as PDAC.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

CAS. Nr.: 1428356-95-9
Formel: C₂₂H₂₃N₉O₂
Molecular Weight:445.48

Speicherung:

Please store the product under the recommended conditions in the Certificate of Analysis.

Data Sheet (277 KB)

CIDD-8633 Chemical Structure

CAS. Nr.: 1428356-95-9

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- IC₅₀ & Target
- In Vitro
- In Vivo
Chemical Information
Lösungsmittel & Löslichkeit
- In Vitro
Reinheit & Dokumentation
Verweise
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

IC₅₀ & Target

^[1]

DDR2

6.105 μM (IC₅₀)

Caspase 3

IL-6

Alle Discoidin Domain Receptor Isoform-spezifische Produkte anzeigen :

DDR1
DDR2

Alle Caspase Isoform-spezifische Produkte anzeigen :

Alle Interleukin Related Isoform-spezifische Produkte anzeigen :

In Vitro

CIDD-8633 (4-5.5 μM, 7-10 days) inhibits the long-term clonal formation ability of AsPC1 and MIA-PaCa-2 cells^[1].
CIDD-8633 (4-6 μM, 72 h) significantly reduces the levels of phosphorylated-DDR2 and its downstream effector phospho-ERK in AsPC1 and MIA-PaCa-2 cells^[1].
CIDD-8633 (1.5 μM, 48 h) inhibits the nuclear translocation of the DDR2-ERK signaling pathway and blocks the proliferative signals in AsPC1 and MIA-PaCa-2 cells^[1].
CIDD-8633 (0.1-10 μM, 72 h) significantly reduces the proliferation of MIA-PaCa-2 cells and AsPC-1 with IC₂₅s of 4.0 and 5.5 μM, respectively^[1].
CIDD-8633 (4 μM, 16 h) reduces the migration ability of MIA PaCa-2 cells by inhibiting DDR2^[1].
CIDD-8633 (4-6 μM, 72 h) inhibits the cell cycle progression by blocking the G1/S phase in AsPC1 and MIA-PaCa-2 cells CIDD-8633 (4-6 μM, 72 h) induces apoptosis in AsPC1 and MIA-PaCa-2 cells by activating caspase-3^[1].
CIDD-8633 (6 μM, 48 h) upregulates the genes including CDKN1A, DDIT3, IL-1β, PMAIP1, and CASP4 in AsPC1 and MIA-PaCa-2 cells^[1].
CIDD-8633 (4-10 μM, 72 h) significantly reduces the levels of p-DDR2 and p-ERK, and increases the level of cleaved caspase-3 in AsPC1 and MIA-PaCa-2 cells^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Immunofluorescence^[1]

Cell Line:

AsPC1 and MIA-PaCa-2 cells
Concentration:

1.5 μM
Incubation Time:

48 h
Result:

Localized the phospho-ERK was predominantly in the nucleus of cells.
Resulted in more cytoplasmic localization of phospho-ERK and a marked decrease in its intensity.

Cell Viability Assay^[1]

Cell Line:

GC68, AsPC1, MIA-PaCa-2, Panc02 and KPC cells
Concentration:

0.1, 1 and 10 μM
Incubation Time:

72 h
Result:

Exhibited IC₅₀s of 6.088, 6.284, 5.025, 4.926 and 10.05 μM, respectively.

Cell Migration Assay ^[1]

Cell Line:

AsPC1 and MIA-PaCa-2 cells
Concentration:

6 μM
Incubation Time:

48 h
Result:

Increased the levels of CDKN1A, DDIT3, IL-1β, PMAIP1 and CASP4.

Apoptosis Analysis^[1]

Cell Line:

AsPC1 and MIA-PaCa-2 cells
Concentration:

4 and 6 μM
Incubation Time:

72 h
Result:

Increased the proportion of apoptotic cells by 2 to 3 times.

Cell Cycle Analysis^[1]

Cell Line:

AsPC1 and MIA-PaCa-2 cells
Concentration:

4 and 6 μM
Incubation Time:

72 h
Result:

Increased the proportion of G1 phase cells by 20-30%.

RT-PCR^[1]

Cell Line:

AsPC1 and MIA-PaCa-2 cells
Concentration:

6 μM
Incubation Time:

48 h
Result:

Increased the levels of CDKN1A, DDIT3, IL-1β, PMAIP1 and CASP4.

Western Blot Analysis^[1]

Cell Line:

AsPC1 and MIA-PaCa-2 cells
Concentration:

4 and 6 μM
Incubation Time:

72 h
Result:

Decreased the levels of p-DDR2 and p-ERK.
Increased the level of cleaved caspase-3.

In Vivo

CIDD-8633 (40 mg/kg, i.p., twice a week for 28 days) exerts anti-tumor effects by targeting DDR2 in mouse models established from MIA PaCa-2 cells and Pan02 cells respectively^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

MIA PaCa-2 induced PDAC model established in NOD/SCID mice^[1]
Dosage:

40 mg/kg
Administration:

Intraperitoneal injection (i.p.), twice a week for 28 days
Result:

Significant decreased the tumor weight and volume.
Decreased the levels of p-DDR2 and p-ERK.

Animal Model:

Pan02 induced PDAC model established in C57BL/6J mice^[1]
Dosage:

40 mg/kg
Administration:

Intraperitoneal injection (i.p.), twice a week for 28 days
Result:

Delayed the tumor growth.
Decreased the levels of p-DDR2 and p-ERK.

Related Protocols :

Chemical Information

CAS. Nr. 1428356-95-9
Molecular Weight 445.48
Formel C₂₂H₂₃N₉O₂
SMILES

O=C(NC1=CC=C(NC2=NC(NCC)=NC(C)=C2)C=C1)COC(C=C3)=NN=C3N4C=CC=N4
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

Please store the product under the recommended conditions in the Certificate of Analysis.

Lösungsmittel & Löslichkeit

In Vitro:

DMSO : 50 mg/mL (112.24 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

2.2448 mL

11.2238 mL

22.4477 mL

5 mM

0.4490 mL

2.2448 mL

4.4895 mL

10 mM

0.2245 mL

1.1224 mL

2.2448 mL

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

Reinheit & Dokumentation

Select Batch:

Reinheit: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (277 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

Verweise

[1]. Do CT, et al. Targeting DDR2 for Treating Pancreatic Cancer. Mol Cancer Ther. 2025 Jun 26. [Content Brief]

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
DMSO	1 mM	2.2448 mL	11.2238 mL	22.4477 mL	56.1192 mL
	5 mM	0.4490 mL	2.2448 mL	4.4895 mL	11.2238 mL
	10 mM	0.2245 mL	1.1224 mL	2.2448 mL	5.6119 mL
	15 mM	0.1497 mL	0.7483 mL	1.4965 mL	3.7413 mL
	20 mM	0.1122 mL	0.5612 mL	1.1224 mL	2.8060 mL
	25 mM	0.0898 mL	0.4490 mL	0.8979 mL	2.2448 mL
	30 mM	0.0748 mL	0.3741 mL	0.7483 mL	1.8706 mL
	40 mM	0.0561 mL	0.2806 mL	0.5612 mL	1.4030 mL
	50 mM	0.0449 mL	0.2245 mL	0.4490 mL	1.1224 mL
	60 mM	0.0374 mL	0.1871 mL	0.3741 mL	0.9353 mL
	80 mM	0.0281 mL	0.1403 mL	0.2806 mL	0.7015 mL
	100 mM	0.0224 mL	0.1122 mL	0.2245 mL	0.5612 mL

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

Angebot einholen Auf Lager

Other size

Angebot einholen

Amount: USD 0.00

Biologische Aktivität
- Beschreibung
- IC₅₀ & Target
- In Vitro
- In Vivo
Chemical Information
Lösungsmittel & Löslichkeit
- In Vitro
Reinheit & Dokumentation
Verweise

Produktname:
Art. -Nr.:
Menge:
MCE Japan Authorized Agent:

Produktname:
CAS. Nr.:
Species:
Reinheit:
Menge:

CIDD-8633

Alle Discoidin Domain Receptor Isoform-spezifische Produkte anzeigen

Alle Caspase Isoform-spezifische Produkte anzeigen

Alle Interleukin Related Isoform-spezifische Produkte anzeigen

Biologische Aktivität

Beschreibung

IC50 & Target

In Vitro

In Vivo

Chemical Information

Lösungsmittel & Löslichkeit

In Vitro:

Reinheit & Dokumentation

Verweise

Help & FAQs

Complete Stock Solution Preparation Table

CIDD-8633 Related Classifications

HY-175202 Related Classifications

Bioz

Keywords

Your Recently Viewed Products

IC₅₀ & Target